{"id":81158,"date":"2018-07-02T18:24:56","date_gmt":"2018-07-02T18:24:56","guid":{"rendered":"http:\/\/dev-erg.pantheonsite.io\/?p=81158"},"modified":"2019-09-27T18:31:47","modified_gmt":"2019-09-27T18:31:47","slug":"erg-participates-in-fda-approval-alkermes-schizophrenia-trial","status":"publish","type":"post","link":"https:\/\/ergclinical.com\/es\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\/","title":{"rendered":"ERG participa en el ensayo de Alkermes para esquizofrenia aprobado por la FDA"},"content":{"rendered":"<div class=\"wpb-content-wrapper\"><div data-parent=\"true\" class=\"vc_row row-container boomapps_vcrow\" id=\"row-unique-0\"><div class=\"row limit-width row-parent\"><div class=\"wpb_row row-inner\"><div class=\"wpb_column pos-top pos-center align_left column_parent col-lg-12 boomapps_vccolumn single-internal-gutter\"><div class=\"uncol style-light\"  ><div class=\"uncoltable\"><div class=\"uncell  boomapps_vccolumn no-block-padding\" ><div class=\"uncont\" ><div class=\"vc_custom_heading_wrap\"><div class=\"heading-text el-text\" ><h2 class=\"h6 text-color-xsdn-color\" ><span>ERG participa en el ensayo de Alkermes para esquizofrenia aprobado por la FDA<\/span><\/h2><\/div><div class=\"clear\"><\/div><\/div><div class=\"uncode_text_column\" ><p>Alkermes plc, ha anunciado que la Administraci\u00f3n de Alimentos y Medicamentos de los Estados Unidos ha aprobado ARISTADA INITIO para el inicio de ARISTADA, un antipsic\u00f3tico at\u00edpico inyectable de acci\u00f3n prolongada para el tratamiento de la esquizofrenia en adultos. El r\u00e9gimen ARISTADA INITIO proporciona a los pacientes niveles relevantes de aripiprazol en los cuatro d\u00edas posteriores al inicio. El resultado es un r\u00e9gimen de inicio alternativo que ofrece a los proveedores de atenci\u00f3n m\u00e9dica una herramienta adicional para apoyar a los pacientes durante un momento cr\u00edtico en su recorrido de tratamiento. St. Louis Clinical Trials, Woodland International Research Group y Woodland Research Northwest felicitan a Alkermes y est\u00e1n orgullosos de haber participado en este ensayo cl\u00ednico de vanguardia.<\/p>\n<\/div><\/div><\/div><\/div><\/div><\/div><script id=\"script-row-unique-0\" data-row=\"script-row-unique-0\" type=\"text\/javascript\" class=\"vc_controls\">UNCODE.initRow(document.getElementById(\"row-unique-0\"));<\/script><\/div><\/div><\/div>\n<\/div>","protected":false},"excerpt":{"rendered":"ERG Participates in FDA Approval Alkermes Schizophrenia TrialAlkermes plc, has announced that the U.S Food and Drug Administration has approved [...]","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_links_to":"","_links_to_target":""},"categories":[82],"tags":[99,109,110,111],"class_list":["post-81158","post","type-post","status-publish","format-standard","hentry","category-news","tag-erg-news","tag-erg-clinical-news","tag-erg-clinical-and-alkermes","tag-new-trial-receives-fda-approval"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ERG Alkermes Schizophrenia Trial Receives FDA Approval - ERG Clinical<\/title>\n<meta name=\"description\" content=\"ERG Clinical sites participated in an Alkermes&#039; Schizophrenia trial that has recieved FDA approval, offering another tool for providers to support patients.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/ergclinical.com\/es\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\/\" \/>\n<meta property=\"og:locale\" content=\"es_MX\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ERG Alkermes Schizophrenia Trial Receives FDA Approval - ERG Clinical\" \/>\n<meta property=\"og:description\" content=\"ERG Clinical sites participated in an Alkermes&#039; Schizophrenia trial that has recieved FDA approval, offering another tool for providers to support patients.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/ergclinical.com\/es\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\/\" \/>\n<meta property=\"og:site_name\" content=\"ERG Clinical\" \/>\n<meta property=\"article:published_time\" content=\"2018-07-02T18:24:56+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2019-09-27T18:31:47+00:00\" \/>\n<meta name=\"author\" content=\"sn3wman\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrito por\" \/>\n\t<meta name=\"twitter:data1\" content=\"sn3wman\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minuto\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/ergclinical.com\\\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ergclinical.com\\\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\\\/\"},\"author\":{\"name\":\"sn3wman\",\"@id\":\"https:\\\/\\\/ergclinical.com\\\/#\\\/schema\\\/person\\\/d723233bb7073ff8ee49c49a1fd90737\"},\"headline\":\"ERG Participates in FDA Approval Alkermes Schizophrenia Trial\",\"datePublished\":\"2018-07-02T18:24:56+00:00\",\"dateModified\":\"2019-09-27T18:31:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/ergclinical.com\\\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\\\/\"},\"wordCount\":141,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/ergclinical.com\\\/#organization\"},\"keywords\":[\"ERG News\",\"ERG Clinical News\",\"ERG Clinical and Alkermes\",\"New Trial Receives FDA Approval\"],\"articleSection\":[\"News\"],\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/ergclinical.com\\\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/ergclinical.com\\\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\\\/\",\"url\":\"https:\\\/\\\/ergclinical.com\\\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\\\/\",\"name\":\"ERG Alkermes Schizophrenia Trial Receives FDA Approval - ERG Clinical\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/ergclinical.com\\\/#website\"},\"datePublished\":\"2018-07-02T18:24:56+00:00\",\"dateModified\":\"2019-09-27T18:31:47+00:00\",\"description\":\"ERG Clinical sites participated in an Alkermes' Schizophrenia trial that has recieved FDA approval, offering another tool for providers to support patients.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/ergclinical.com\\\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/ergclinical.com\\\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/ergclinical.com\\\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/ergclinical.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ERG Participates in FDA Approval Alkermes Schizophrenia Trial\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/ergclinical.com\\\/#website\",\"url\":\"https:\\\/\\\/ergclinical.com\\\/\",\"name\":\"ERG Clinical\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/ergclinical.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/ergclinical.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/ergclinical.com\\\/#organization\",\"name\":\"ERG Clinical\",\"url\":\"https:\\\/\\\/ergclinical.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/ergclinical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/ergclinical.com\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/erg-site-icon-512-lt.png\",\"contentUrl\":\"https:\\\/\\\/ergclinical.com\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/erg-site-icon-512-lt.png\",\"width\":512,\"height\":512,\"caption\":\"ERG Clinical\"},\"image\":{\"@id\":\"https:\\\/\\\/ergclinical.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/ergclinical.com\\\/#\\\/schema\\\/person\\\/d723233bb7073ff8ee49c49a1fd90737\",\"name\":\"sn3wman\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/794a54230606575758df2833c7723dd407f4d86875275da007ad5212ec846e9d?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/794a54230606575758df2833c7723dd407f4d86875275da007ad5212ec846e9d?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/794a54230606575758df2833c7723dd407f4d86875275da007ad5212ec846e9d?s=96&d=mm&r=g\",\"caption\":\"sn3wman\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"El ensayo cl\u00ednico ERG Alkermes para la esquizofrenia recibe la aprobaci\u00f3n de la FDA - ERG Clinical","description":"Los sitios cl\u00ednicos de ERG participaron en un ensayo de esquizofrenia de Alkermes que recibi\u00f3 la aprobaci\u00f3n de la FDA y ofrece otra herramienta para que los proveedores apoyen a los pacientes.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/ergclinical.com\/es\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\/","og_locale":"es_MX","og_type":"article","og_title":"ERG Alkermes Schizophrenia Trial Receives FDA Approval - ERG Clinical","og_description":"ERG Clinical sites participated in an Alkermes' Schizophrenia trial that has recieved FDA approval, offering another tool for providers to support patients.","og_url":"https:\/\/ergclinical.com\/es\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\/","og_site_name":"ERG Clinical","article_published_time":"2018-07-02T18:24:56+00:00","article_modified_time":"2019-09-27T18:31:47+00:00","author":"sn3wman","twitter_card":"summary_large_image","twitter_misc":{"Escrito por":"sn3wman","Tiempo de lectura":"1 minuto"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/ergclinical.com\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\/#article","isPartOf":{"@id":"https:\/\/ergclinical.com\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\/"},"author":{"name":"sn3wman","@id":"https:\/\/ergclinical.com\/#\/schema\/person\/d723233bb7073ff8ee49c49a1fd90737"},"headline":"ERG Participates in FDA Approval Alkermes Schizophrenia Trial","datePublished":"2018-07-02T18:24:56+00:00","dateModified":"2019-09-27T18:31:47+00:00","mainEntityOfPage":{"@id":"https:\/\/ergclinical.com\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\/"},"wordCount":141,"commentCount":0,"publisher":{"@id":"https:\/\/ergclinical.com\/#organization"},"keywords":["ERG News","ERG Clinical News","ERG Clinical and Alkermes","New Trial Receives FDA Approval"],"articleSection":["News"],"inLanguage":"es","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/ergclinical.com\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/ergclinical.com\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\/","url":"https:\/\/ergclinical.com\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\/","name":"El ensayo cl\u00ednico ERG Alkermes para la esquizofrenia recibe la aprobaci\u00f3n de la FDA - ERG Clinical","isPartOf":{"@id":"https:\/\/ergclinical.com\/#website"},"datePublished":"2018-07-02T18:24:56+00:00","dateModified":"2019-09-27T18:31:47+00:00","description":"Los sitios cl\u00ednicos de ERG participaron en un ensayo de esquizofrenia de Alkermes que recibi\u00f3 la aprobaci\u00f3n de la FDA y ofrece otra herramienta para que los proveedores apoyen a los pacientes.","breadcrumb":{"@id":"https:\/\/ergclinical.com\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/ergclinical.com\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/ergclinical.com\/erg-participates-in-fda-approval-alkermes-schizophrenia-trial\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/ergclinical.com\/"},{"@type":"ListItem","position":2,"name":"ERG Participates in FDA Approval Alkermes Schizophrenia Trial"}]},{"@type":"WebSite","@id":"https:\/\/ergclinical.com\/#website","url":"https:\/\/ergclinical.com\/","name":"ERG Cl\u00ednico","description":"","publisher":{"@id":"https:\/\/ergclinical.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/ergclinical.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/ergclinical.com\/#organization","name":"ERG Cl\u00ednico","url":"https:\/\/ergclinical.com\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/ergclinical.com\/#\/schema\/logo\/image\/","url":"https:\/\/ergclinical.com\/wp-content\/uploads\/2019\/05\/erg-site-icon-512-lt.png","contentUrl":"https:\/\/ergclinical.com\/wp-content\/uploads\/2019\/05\/erg-site-icon-512-lt.png","width":512,"height":512,"caption":"ERG Clinical"},"image":{"@id":"https:\/\/ergclinical.com\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/ergclinical.com\/#\/schema\/person\/d723233bb7073ff8ee49c49a1fd90737","name":"hombre sn3w","image":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/secure.gravatar.com\/avatar\/794a54230606575758df2833c7723dd407f4d86875275da007ad5212ec846e9d?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/794a54230606575758df2833c7723dd407f4d86875275da007ad5212ec846e9d?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/794a54230606575758df2833c7723dd407f4d86875275da007ad5212ec846e9d?s=96&d=mm&r=g","caption":"sn3wman"}}]}},"_links":{"self":[{"href":"https:\/\/ergclinical.com\/es\/wp-json\/wp\/v2\/posts\/81158","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ergclinical.com\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ergclinical.com\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ergclinical.com\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ergclinical.com\/es\/wp-json\/wp\/v2\/comments?post=81158"}],"version-history":[{"count":0,"href":"https:\/\/ergclinical.com\/es\/wp-json\/wp\/v2\/posts\/81158\/revisions"}],"wp:attachment":[{"href":"https:\/\/ergclinical.com\/es\/wp-json\/wp\/v2\/media?parent=81158"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ergclinical.com\/es\/wp-json\/wp\/v2\/categories?post=81158"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ergclinical.com\/es\/wp-json\/wp\/v2\/tags?post=81158"}],"curies":[{"name":"gracias","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}